Dementia is the progressive loss of normal cognitive function, which can occur sporadically due to a genetic predisposition or in relation to chronic cerebrovascular disease. HTML OverviewOur research aim is to understand in detail the biology & expression of neurodegenerative disease decades before symptoms of dementia appear. This includes very comprehensive assessment through neuroimaging, blood & CSF tests of this biology & detailed cognitive testing as well as early neuropsychiatric features such as sleep disturbance.We also assess fixed & modifiable risks to determine what factors mediate dais onset & progression.Edinburgh is a hub/centre in the UK Dementia Research Institute (UK-DRI) with a programme found on vascular dementia and is leading a large UK-wide study about vascular dementia (R4VaD). Projects led from Edinburgh (EPAD& PREVENT Dementia, LBC1936, Mild Stroke Study 3, R4VaD) also assess people longitudinally allowing us to model not only cross-sectional associations but also longitudinal trajectories. We now work on projects that try to improve detection of early markers of dementia from the appearance of the back of the eye.Ultimately we aim to create disease & clinical models that can be applied at both a personal & population level to impact on the course of neurodegenerative disease & therein prevent dementia.Lead dementia researcher Prof Joanna Wardlaw To discuss new research & collaborative imaging projects with Edinburgh Imaging, please contact: Edinburgh Imaging Enquiries: studies / collaborations / facilities Contact details Email: edimg.studyinfo@ed.ac.uk Research staff with a dementia focusDr Lucia BalleriniDr Mark BastinDr David R GonzalezDr Maria Valdés HernándezDr Dominic JobProf Ian MarshallDr Susana Munoz-ManiegaDr Carol Di PerriProf Craig RitchieDr Susan ShenkinDr Michael ThrippletonProf Adam WaldmanDr Stewart WisemanCurrent projectsCompleted projects Funding organisations & groupsOrganisations are listed alphabetically:Age UKAlzheimer’s SocietyBritish Heat FoundationEPSRCInnovative Medicines Initiative (EU IMI)JanssenMedical Research Council (MRC)Stroke AssociationRelevant linksNIHR Dementia Researcher07 Oct 21. UK DRI Edinburgh: BBB in dementia09 Mar 21. PREVENT Dementia study milestone14 Sep 20. RSM virtual meeting05 Jul 18. Drug hope for dementia & strokeRelevant Edinburgh Imaging publications17 Apr 23. Featured Paper. Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer’s disease and neurodegeneration stratified by sex27 May 22. Featured Paper. Network impact score is an independent predictor of post-stroke cognitive impairment: A multicenter cohort study in 2341 patients with acute ischemic stroke09 Feb 22. Featured Paper. Blood–brain barrier link to human cognitive impairment and Alzheimer’s disease17 Nov 21. Featured Paper. Prevalence of dementia in ischaemic or mixed stroke populations: systematic review & meta-analysis06 Oct 21. Featured Paper. Predicting post-stroke cognitive impairment using acute CT neuroimaging: A systematic review & meta-analysis01 Jun 21. Featured Paper. Correlations in post-mortem imaging-histopathology studies of sporadic human cerebral small vessel disease: a systematic review26 May 21. Featured Paper. Sources of systematic error in DCE-MRI estimation of low-level blood-brain barrier leakage.13 May 21. Featured Paper. ESO Guideline on covert cerebral small vessel disease.11 Mar 21. Featured Paper. The application of optical coherence tomography angiography in Alzheimer's disease: A systematic review.11 Feb 21. Featured Paper. Neuropsychiatric symptoms associated with cerebral small vessel disease: a systematic review & meta-analysis.Please view all our publications, here This article was published on 2024-08-22
HTML OverviewOur research aim is to understand in detail the biology & expression of neurodegenerative disease decades before symptoms of dementia appear. This includes very comprehensive assessment through neuroimaging, blood & CSF tests of this biology & detailed cognitive testing as well as early neuropsychiatric features such as sleep disturbance.We also assess fixed & modifiable risks to determine what factors mediate dais onset & progression.Edinburgh is a hub/centre in the UK Dementia Research Institute (UK-DRI) with a programme found on vascular dementia and is leading a large UK-wide study about vascular dementia (R4VaD). Projects led from Edinburgh (EPAD& PREVENT Dementia, LBC1936, Mild Stroke Study 3, R4VaD) also assess people longitudinally allowing us to model not only cross-sectional associations but also longitudinal trajectories. We now work on projects that try to improve detection of early markers of dementia from the appearance of the back of the eye.Ultimately we aim to create disease & clinical models that can be applied at both a personal & population level to impact on the course of neurodegenerative disease & therein prevent dementia.Lead dementia researcher Prof Joanna Wardlaw To discuss new research & collaborative imaging projects with Edinburgh Imaging, please contact: Edinburgh Imaging Enquiries: studies / collaborations / facilities Contact details Email: edimg.studyinfo@ed.ac.uk Research staff with a dementia focusDr Lucia BalleriniDr Mark BastinDr David R GonzalezDr Maria Valdés HernándezDr Dominic JobProf Ian MarshallDr Susana Munoz-ManiegaDr Carol Di PerriProf Craig RitchieDr Susan ShenkinDr Michael ThrippletonProf Adam WaldmanDr Stewart WisemanCurrent projectsCompleted projects Funding organisations & groupsOrganisations are listed alphabetically:Age UKAlzheimer’s SocietyBritish Heat FoundationEPSRCInnovative Medicines Initiative (EU IMI)JanssenMedical Research Council (MRC)Stroke AssociationRelevant linksNIHR Dementia Researcher07 Oct 21. UK DRI Edinburgh: BBB in dementia09 Mar 21. PREVENT Dementia study milestone14 Sep 20. RSM virtual meeting05 Jul 18. Drug hope for dementia & strokeRelevant Edinburgh Imaging publications17 Apr 23. Featured Paper. Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer’s disease and neurodegeneration stratified by sex27 May 22. Featured Paper. Network impact score is an independent predictor of post-stroke cognitive impairment: A multicenter cohort study in 2341 patients with acute ischemic stroke09 Feb 22. Featured Paper. Blood–brain barrier link to human cognitive impairment and Alzheimer’s disease17 Nov 21. Featured Paper. Prevalence of dementia in ischaemic or mixed stroke populations: systematic review & meta-analysis06 Oct 21. Featured Paper. Predicting post-stroke cognitive impairment using acute CT neuroimaging: A systematic review & meta-analysis01 Jun 21. Featured Paper. Correlations in post-mortem imaging-histopathology studies of sporadic human cerebral small vessel disease: a systematic review26 May 21. Featured Paper. Sources of systematic error in DCE-MRI estimation of low-level blood-brain barrier leakage.13 May 21. Featured Paper. ESO Guideline on covert cerebral small vessel disease.11 Mar 21. Featured Paper. The application of optical coherence tomography angiography in Alzheimer's disease: A systematic review.11 Feb 21. Featured Paper. Neuropsychiatric symptoms associated with cerebral small vessel disease: a systematic review & meta-analysis.Please view all our publications, here